Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients

E. Hsin Yu, How-Ran Guo, Ta Jen Wu

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Aims: To assess the factors associated with successful discontinuation of insulin therapy after diabetic ketoacidosis (DKA) in adult patients. Methods: Patients (≥ 18 years) attending the Endocrine and Metabolism Clinic at a major hospital in southern Taiwan were recruited. After recovery from the acute stage, those with no contraindications to oral antidiabetic agents, with adequate β cell reserve, and with no antiglutamic acid decarboxylase (GAD) antibody were treated with oral agents. Results: Sixty-six patients (38 males, 28 females, aged 18-76 years) were included, and 21 qualified for treatment with oral agents. These 21 patients were older at diagnosis of diabetes (45.5 ± 14.0 vs. 40.0 ± 13.8 years, P = 0.047), had shorter diabetes duration (median 0 vs. 5.5 months, P = 0.040), higher BMI (median 23.4 vs. 19.5 kg/m2, P < 0.001), higher serum osmolality during DKA (352.1 ± 40.7 vs. 318.0 ± 16.4 mmol/kg, P = 0.005), and lower insulin dose following recovery (median 0.49 vs. 0.83 unit/kg/d, P < 0.001) than those patients that had to continue insulin therapy. Thirteen patients (8 males, 5 females; 62%) successfully discontinued insulin for at least one year without recurrence of DKA. Multiple logistic regression analyses showed that BMI ≥ 25 kg/m2 (adjusted relative risk (ARR) 8.85, 95% CI 1.05, 8.39), diabetes onset age ≥ 40 years (ARR 8.08, 95% CI 1.16, 6.95), and undiagnosed diabetes before DKA (ARR 8.90, 95% CI 1.19, 7.51) were significant factors associated with successful discontinuation of insulin therapy. Conclusion: We identified three independent clinical factors associated with successful discontinuation of insulin therapy after DKA.

Original languageEnglish
Pages (from-to)895-899
Number of pages5
JournalDiabetic Medicine
Volume18
Issue number11
DOIs
Publication statusPublished - 2001 Dec 1

Fingerprint

Diabetic Ketoacidosis
Insulin
Therapeutics
Carboxy-Lyases
Taiwan
Age of Onset
Hypoglycemic Agents
Osmolar Concentration
Logistic Models
Regression Analysis
Recurrence
Acids
Antibodies
Serum

All Science Journal Classification (ASJC) codes

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{aece4164fa59497cb5caab1a750f3ed0,
title = "Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients",
abstract = "Aims: To assess the factors associated with successful discontinuation of insulin therapy after diabetic ketoacidosis (DKA) in adult patients. Methods: Patients (≥ 18 years) attending the Endocrine and Metabolism Clinic at a major hospital in southern Taiwan were recruited. After recovery from the acute stage, those with no contraindications to oral antidiabetic agents, with adequate β cell reserve, and with no antiglutamic acid decarboxylase (GAD) antibody were treated with oral agents. Results: Sixty-six patients (38 males, 28 females, aged 18-76 years) were included, and 21 qualified for treatment with oral agents. These 21 patients were older at diagnosis of diabetes (45.5 ± 14.0 vs. 40.0 ± 13.8 years, P = 0.047), had shorter diabetes duration (median 0 vs. 5.5 months, P = 0.040), higher BMI (median 23.4 vs. 19.5 kg/m2, P < 0.001), higher serum osmolality during DKA (352.1 ± 40.7 vs. 318.0 ± 16.4 mmol/kg, P = 0.005), and lower insulin dose following recovery (median 0.49 vs. 0.83 unit/kg/d, P < 0.001) than those patients that had to continue insulin therapy. Thirteen patients (8 males, 5 females; 62{\%}) successfully discontinued insulin for at least one year without recurrence of DKA. Multiple logistic regression analyses showed that BMI ≥ 25 kg/m2 (adjusted relative risk (ARR) 8.85, 95{\%} CI 1.05, 8.39), diabetes onset age ≥ 40 years (ARR 8.08, 95{\%} CI 1.16, 6.95), and undiagnosed diabetes before DKA (ARR 8.90, 95{\%} CI 1.19, 7.51) were significant factors associated with successful discontinuation of insulin therapy. Conclusion: We identified three independent clinical factors associated with successful discontinuation of insulin therapy after DKA.",
author = "{Hsin Yu}, E. and How-Ran Guo and Wu, {Ta Jen}",
year = "2001",
month = "12",
day = "1",
doi = "10.1046/j.0742-3071.2001.00596.x",
language = "English",
volume = "18",
pages = "895--899",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "11",

}

Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients. / Hsin Yu, E.; Guo, How-Ran; Wu, Ta Jen.

In: Diabetic Medicine, Vol. 18, No. 11, 01.12.2001, p. 895-899.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients

AU - Hsin Yu, E.

AU - Guo, How-Ran

AU - Wu, Ta Jen

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Aims: To assess the factors associated with successful discontinuation of insulin therapy after diabetic ketoacidosis (DKA) in adult patients. Methods: Patients (≥ 18 years) attending the Endocrine and Metabolism Clinic at a major hospital in southern Taiwan were recruited. After recovery from the acute stage, those with no contraindications to oral antidiabetic agents, with adequate β cell reserve, and with no antiglutamic acid decarboxylase (GAD) antibody were treated with oral agents. Results: Sixty-six patients (38 males, 28 females, aged 18-76 years) were included, and 21 qualified for treatment with oral agents. These 21 patients were older at diagnosis of diabetes (45.5 ± 14.0 vs. 40.0 ± 13.8 years, P = 0.047), had shorter diabetes duration (median 0 vs. 5.5 months, P = 0.040), higher BMI (median 23.4 vs. 19.5 kg/m2, P < 0.001), higher serum osmolality during DKA (352.1 ± 40.7 vs. 318.0 ± 16.4 mmol/kg, P = 0.005), and lower insulin dose following recovery (median 0.49 vs. 0.83 unit/kg/d, P < 0.001) than those patients that had to continue insulin therapy. Thirteen patients (8 males, 5 females; 62%) successfully discontinued insulin for at least one year without recurrence of DKA. Multiple logistic regression analyses showed that BMI ≥ 25 kg/m2 (adjusted relative risk (ARR) 8.85, 95% CI 1.05, 8.39), diabetes onset age ≥ 40 years (ARR 8.08, 95% CI 1.16, 6.95), and undiagnosed diabetes before DKA (ARR 8.90, 95% CI 1.19, 7.51) were significant factors associated with successful discontinuation of insulin therapy. Conclusion: We identified three independent clinical factors associated with successful discontinuation of insulin therapy after DKA.

AB - Aims: To assess the factors associated with successful discontinuation of insulin therapy after diabetic ketoacidosis (DKA) in adult patients. Methods: Patients (≥ 18 years) attending the Endocrine and Metabolism Clinic at a major hospital in southern Taiwan were recruited. After recovery from the acute stage, those with no contraindications to oral antidiabetic agents, with adequate β cell reserve, and with no antiglutamic acid decarboxylase (GAD) antibody were treated with oral agents. Results: Sixty-six patients (38 males, 28 females, aged 18-76 years) were included, and 21 qualified for treatment with oral agents. These 21 patients were older at diagnosis of diabetes (45.5 ± 14.0 vs. 40.0 ± 13.8 years, P = 0.047), had shorter diabetes duration (median 0 vs. 5.5 months, P = 0.040), higher BMI (median 23.4 vs. 19.5 kg/m2, P < 0.001), higher serum osmolality during DKA (352.1 ± 40.7 vs. 318.0 ± 16.4 mmol/kg, P = 0.005), and lower insulin dose following recovery (median 0.49 vs. 0.83 unit/kg/d, P < 0.001) than those patients that had to continue insulin therapy. Thirteen patients (8 males, 5 females; 62%) successfully discontinued insulin for at least one year without recurrence of DKA. Multiple logistic regression analyses showed that BMI ≥ 25 kg/m2 (adjusted relative risk (ARR) 8.85, 95% CI 1.05, 8.39), diabetes onset age ≥ 40 years (ARR 8.08, 95% CI 1.16, 6.95), and undiagnosed diabetes before DKA (ARR 8.90, 95% CI 1.19, 7.51) were significant factors associated with successful discontinuation of insulin therapy. Conclusion: We identified three independent clinical factors associated with successful discontinuation of insulin therapy after DKA.

UR - http://www.scopus.com/inward/record.url?scp=0035685524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035685524&partnerID=8YFLogxK

U2 - 10.1046/j.0742-3071.2001.00596.x

DO - 10.1046/j.0742-3071.2001.00596.x

M3 - Article

C2 - 11703434

AN - SCOPUS:0035685524

VL - 18

SP - 895

EP - 899

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 11

ER -